Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VeRA: VX-702 in moderate to severe rheumatoid arthritis
NCT00205478Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of vx-702 in rheumatoid arthritis (RA), sponsored by Vertex Pharmaceuticals. Started Jun 2005; status: completed.
02
Drugs
vx-702
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00205478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00205478.